South Africa to host two international migraine studies
South Africa has been selected to host two ground breaking international studies into the causes of migraine headaches.
The decision to choose South Africa was taken in Italy in June after specialists reviewed research protocols and compared facilities.
The first study will focus on mapping the ‘migraine code'. The ‘migraine code' is a phrase used to describe the sequence of anatomical and physiological disruptions that result in, and cause, the excruciating pain of migraine. This sequence will be mapped by gathering a web of data from thousands of migraine sufferers from Johannesburg, Durban, and Cape Town, and abroad.
The study will make use of the latest CT angiogram imaging and scanning technology. This provides a three dimensional visual analysis of the anatomy of the head, face, and neck areas allowing the sequence of pathologies, or the ‘migraine code' to be mapped.
In the second study, tissue samples from South African migraine sufferers will be couriered to a laboratory in Italy in the hope of breaking fresh ground in the development of a new breed of pharmaceuticals. Researchers are remaining tight lipped on the details and research protocols of this effort to pioneer more effective migraine medications.
According to the Chairman of the South African Headache Society (SAHS) Dr Elliot Shevel, The Headache Clinic in South Africa is the largest migraine treatment facility in the world measured by patient flow. This factor gave South Africa the edge as the destination of choice for Italian migraine specialist and Professor of Neuropsychiatry Carlo Ciancetti and his associates, who have teamed up with South Africa's migraine surgery pioneer, Dr Shevel.
Both these research projects are being funded jointly by the governments of Italy and South Africa. “According to the government's grant, the time frame for the initial phase of the research is three years. But with the assistance of my colleagues at The European Headache Society, the American Headache Society, and at Harvard Medical School, we expect to reach completion and publication of the first stage within a year.” stated Dr Shevel on his return from Italy in June.
Issued by Idea Engineers on behalf of The Headache Clinic
Editorial contact
Ima Peter - Idea Engineers
Tel:+27 (0) 11 803-0030
Cell: 076 119 4109
Email: